Amgen owes $406 million for monopolizing cholesterol drug market, US jury says A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for engaging in anticompetitive behavior to increase sales of its cholesterol-reduction drug Repatha at the expense of Regeneron’s rival drug Praluent.The jury agreed with Regener … Read More >>
The 2:59 PM Trade [sponsor] It’s Friday afternoon, 2:59 pm. Most traders are clocking out. But legendary Millionaire trader Tim Sykes is about to cash in on a strange weekend “loophole.” He’s used this exact method to make $8,780… $9,518… and even $16,159 over the weekend. But today, he wants to show YOU how to do it too. >> Click here to play video.
Hidden Gem’s – Tomorrow’s Market Secrets – Delivered Today Chip stocks have been heating up again, driven by renewed AI enthusiasm and capital inflows ahead of Computex 2025 (June 2â5). Names like NVIDIA (NVDA) and AMD are showing strong relative strength as demand for next-gen GPUs builds. Watch SMH, the semiconductor ETF, for clues on broader momentum.NVDA rec … Read More >>
Top investors are buying this “unlisted” stock [sponsor] When the team that created Zillow and grew it to a $16B valuation starts a new company, investors notice. No wonder top firms like SoftBank already invested in Pacaso. Taking the industry by storm all over again, Pacaso’s streamlined platform offers co-ownership of premier properties – revamping a $1.3T market. By handing keys to 2,000 happy homeowners, Pacaso has made $110M in gross profits. Join leading investors as a Pacaso shareholder for just $2.80/share before their price changes 5/29This is a paid advertisement for Pacaso’s Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
CVS bids for Rite Aid stores, patient data in Pacific Northwest, Bloomberg News reports CVS put in a bid for stores in Washington, Oregon, and Idaho, as well as patient prescription information, Rite Aid CEO Matthew Schroeder told employees, according to a recording of the meeting reviewed by Bloomberg News.Rite Aid has also received multiple bids on some of its pharmacy assets, such as patient … Read More >>
UnitedHealth shares slide as criminal probe report adds to investor fears The latest news adds to the health insurer’s litany of woes, including multiple government inquiries, a sudden change in top leadership and a pulled outlook in the face of soaring medical costs. Investors and analysts noted that while details on the investigation were limited, they did heighten investor conce … Read More >>
IMPORTANT NOTICE AND DISCLAIMER GBM Media Group, LLC (“GBM”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. GBM has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. GBM will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.
FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE. This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.
SUBSTANTIAL RISK IN INVESTMENT. Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.
NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER Neither GBM nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.
At Stock Focus Report, it’s our mission to create and provide a community that helps you invest and understand stocks. When stockfocusreport was established, we wanted to make the community an inclusive place where investors can come to get ahead! Not just help them with daily stock picks. Stock Focus Report are provided to you for information only and should not be considered as a stock or investment advisor. Stock Focus Report may make available certain information related to trading strategies and stock prices for educational and information purposes only; any information made available should not be construed as an endorsement, recommendation, or sponsorship of any company or security. By visiting this site or using the training materials, you acknowledge and agree that any reliance upon the content or data available through Stock Focus Report is at your own sole risk. You are strongly advised to use your own judgment, research, and consult a professional advisor.
Over the years, and with thousands of followers that use our stock picks daily, we promise to always aim to get better at what we do every single day! In addition, our primary focus is on our communication with you. It’s really important to us that every time you come to us, you end up leaving with the help you came for to take your investment portfolio to new levels.
We particularly appreciate when our following provides feedback via testimonials, reviews, and comments left on our site or social media accounts. Because with that feedback, we can use it to make your next visit to our site even better than the last!
Since we put so much effort into the relationship with you, we hope that any investment in us is exactly the way you hoped it would be. Because by choosing to go with https://stockfocusreport.com/, it’s our promise that we provide a community you will come back to over and over again.
Now, as much as we care about making investors more successful, we also care about your privacy. Stock Focus Report is owned and operated by stockfocusreport website.
We’re committed to the right to your privacy and strive to provide a safe and secure user experience. Our Privacy Policy explains how we collect, store and use personal information, provided by you on our website.
What Information Do We Collect?
When you visit our Web site you may provide us with two types of information: personal information you knowingly choose to disclose that is collected on an individual basis and Web site use information collected on an aggregate basis as you and others browse our Web site.
For example, you may need to provide the following information: • Name • Website URL information • Email address • Home and business phone number
In addition to providing the foregoing information, if you choose to correspond further with us through email, we may retain the content of your email messages together with your email address and our responses. We provide the same protections for these electronic communications that we employ in the maintenance of information received by mail and telephone. It also explains important information that ensures we won’t abuse the information that you provide to us in good faith. By accessing and using our website, you can trust that what you want to be kept private, will be kept private. If at any time, you would like to read our Privacy Policy and get a better understanding of your rights and liabilities under the law.
Feel free to visit our site, find the privacy policy in the footer and read it. If there is something you are concerned about or wish to get more clarity on, please let us know by contacting us at [email protected]. The Privacy Policy also informs you of how to notify us to stop using your personal information. If you wish to view our official policies, please visit our website https://stockfocusreport.com/
At Stock Focus Report, we are strongly committed to protecting your privacy and providing a safe & high-quality online experience for all of our visitors. We understand that you care about how the information you provide to us is used and shared. We have developed a Privacy Policy to inform you of our policies regarding the collection, use, and disclosure of information we receive from users of our website. Stock Focus Report operates the Website.
Our Privacy Policy, along with our Term & Conditions, governs your use of this site. By using https://stockfocusreport.com/, or by accepting the Terms of Use (via opt-in, checkbox, pop-up, or clicking an email link confirming the same), you agree to be bound by our Terms & Conditions and our Privacy Policy. If you have provided personal, billing, or other voluntarily provided information, you may access, review, and make changes to it via instructions found on the Website or by emailing us at [email protected]. To manage your receipt of marketing and non-transactional communications, you may unsubscribe by clicking the “unsubscribe” link located on the bottom of any marketing email. Emails related to the purchase or delivery of orders are provided automatically – Customers are not able to opt out of transactional emails. We will try to accommodate any requests related to the management of Personal Information in a timely manner. However, it is not always possible to completely remove or modify information in our databases (for example, if we have a legal obligation to keep it for certain timeframes, for example). If you have any questions, simply reply to this email or visit our website to view our official policies.
